Nahdi Medical Company (4164.SR) SAU
Currency In SAR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.35B |
| Enterprise Value | 13.58B |
| P/E Ratio | 14.08 |
| PEG Ratio | -2.65 |
| Price/Sales Ratio | 1.05 |
| Price/Book Ratio | 4.42 |
| Enterprise/Revenue | 1.21 |
| Enterprise/EBITDA | 7.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.12 |
| Return On Equity | 0.3 |
Income Statement
| Revenue | 10.21B |
| Revenue/Share | 80.92 |
| Gross Profit | 3.81B |
| EBITDA | 1.69B |
| Net Income | 830.7M |
| Diluted EPS | 6.39 |
Balance Sheet
| Total Cash | 512.82M |
| Total Cash/Share | 3.94 |
| Total Debt | 1.76B |
| Total Debt/Equity | 0.7 |
| Current Ratio | 1.28 |
| Book Value Per Share | 19.32 |
Price History
| 52-Week Change | -27.24 |
| 52-Week High | 120.9 |
| 52-Week Low | 85.2 |
| Moving Average 50 Days | 91.77 |
| Moving Average 200 Days | 96.9 |
Statistics
| Average Volume | 111,276 |
| Shares Outstanding | 130M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 5.6 |
| Trailing Annual Dividend Yield | 6.56 |
| Payout Ratio | 0.92 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
